Normal breast epithelial cells induce apoptosis of breast cancer cells via Fas signaling

被引:33
作者
Toillon, RA
Descamps, S
Adriaenssens, E
Ricort, JM
Bernard, D
Boilly, B
Le Bourhis, X [1 ]
机构
[1] Univ Sci & Tech Lille Flandres Artois, Dev Biol Lab, UPRES EA 1033, SN3,Equipe Facteurs Croissance, F-59655 Villeneuve Dascq, France
[2] Hop St Antoine, Unite INSERM 515, F-75571 Paris, France
[3] Inst Biol Lille, EP560, Lille, France
关键词
normal breast epithelial cells; breast cancer; apoptosis; Fas; PI3; kinase; NF-kappa B;
D O I
10.1006/excr.2002.5490
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fas/Fas ligand (Fas L) death pathway is an important mediator of apoptosis. Deregulation of Fas pathway is reported to be involved in the immune escape of breast cancer and the resistance to anti-cancer drugs. In this study, we demonstrated that conditioned medium by normal breast epithelial cells (NBEC-CM) induced apoptosis of MCF-7 and T-47D Fas-sensitive cells but had no effect on MDA-MB-231 Fas-resistant cells. Inhibition of PI3 kinase or NF-kappaB by specific inhibitors or transient transfections restored the sensitivity of MDA-MB-231 cells to NBEC-induced apoptosis. Moreover, the constitutive activation of NF-kappaB was controlled by PI3 kinase because inhibition of PI3 kinase reduced NF-kappaB activity. Inducible activation of NF-kappaB rendered MCF-7 cells resistant to NBEC-CM- and Fas agonist antibody-triggered apoptosis. Therefore, constitutive or inducible activation of PI3 kinase and/or NF-kappaB in breast cancer cells rendered them resistant to NBEC-triggered apoptosis. In addition, Fas neutralizing antibody and dominant negative Fas abolished NBEC-triggered apoptosis. Western blot and confocal microscopy analysis showed an increase of membrane Fas/Fas L when cells were induced into apoptotis by NBEC-CM. Taken together, these data show that NBEC induced apoptosis in breast cancer cells via Fas signaling. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:31 / 43
页数:13
相关论文
共 57 条
[51]  
Toillon Robert-Alain, 2000, Molecular Cell Biology Research Communications, V3, P338, DOI 10.1006/mcbr.2000.0236
[52]   Cell death in development [J].
Vaux, DL ;
Korsmeyer, SJ .
CELL, 1999, 96 (02) :245-254
[53]   PROTOONCOGENE BCL-2 GENE-TRANSFER ABROGATES FAS/APO-1 ANTIBODY-MEDIATED APOPTOSIS OF HUMAN-MALIGNANT GLIOMA-CELLS AND CONFERS RESISTANCE TO CHEMOTHERAPEUTIC DRUGS AND THERAPEUTIC IRRADIATION [J].
WELLER, M ;
MALIPIERO, U ;
AGUZZI, A ;
REED, JC ;
FONTANA, A .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2633-2643
[54]   New directions in breast cancer research [J].
Wolman, SR ;
Heppner, GH ;
Wolman, E .
FASEB JOURNAL, 1997, 11 (07) :535-543
[55]  
Wyllie AH, 1999, BRIT J CANCER, V80, P34
[56]   REQUIREMENT FOR PHOSPHATIDYLINOSITOL-3 KINASE IN THE PREVENTION OF APOPTOSIS BY NERVE GROWTH-FACTOR [J].
YAO, RJ ;
COOPER, GM .
SCIENCE, 1995, 267 (5206) :2003-2006
[57]  
Yu WP, 1999, CANCER RES, V59, P953